Selatogrel (ACT-246475) is a reversible and selective P2Y 12 receptor antagonist which inhibits platelet aggregation with an IC 50 of 8 nM. Selatogrel exhibits antithrombotic efficacy.
Products | Products > Disease Areas > Blood or Cardio-cerebrovascular Disease | Products > Disease Areas > Cardiovascular Disease | Products > Signaling Pathways > GPCR/G Protein | Products > Research Areas > Cardiovascular Disease | Products > Signaling Pathways > P2Y Receptor
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.